13569.rar -

This research, likely part of the dataset, analyzed tumor sequencing to identify the amplification of genes such as MDM2 and CDK4 in 12q14-15. It connects these molecular findings to survival and metastasis rates in patients, noting that MDM2 amplification is a key marker distinguishing DDLPS from benign tumors.

Immune checkpoint inhibitors in sarcomas: a systematic review 13569.rar

Research into PRAME as an immunotherapy target in sarcoma subtypes. This research, likely part of the dataset, analyzed

Other related research topics often found in similar databases include: likely part of the dataset